Pseudomonas aeruginosa toxin A and diphtheria toxin both inhibit eucaryotic protein synthesis by catalyzing the NAD-dependent ADP ribosylation of EF2 (7, 13) . The ADP-ribosyl transferase activities of these two toxins are remarkably similar if not identical (5, 13, 14) . Fragment A of diphtheria toxin and a 26,000 to 27,000-dalton, enzymatically active fragment from toxin A have similar Michaelis constants (Km's) for NAD and EF-2 (8 and 15 ,tM, respectively) and similar inhibition constants (Ki's) for a variety of analogs. In addition, the ADPribosyl transferase reaction catalyzed by fragment A of diphtheria toxin can be reversed by toxin A or its enzymatically active fragment or vice versa (5, 14) . These data suggest at least partial homology between these two toxins. Demonstration of immunological cross-reactivity between toxin A and diphtheria toxin would support this contention, but this has not been possible by immunodiffusion analysis (16) , enzyme neutralization (13) , or cross-neutralization of tissue culture cytotoxicity (18) .
We have examined the possibility of homology between toxin A and diphtheria toxin by utilizing a very sensitive solid-phase radioimmunoassay inhibition system (SPRIA inhibition) and DNA-DNA hybridization with DNA from ,-tox+ corynebacteriophage (3) and the toxin A+ P aeruginosa strain PA103. Crossreactivity was demonstrated by using the SPRIA inhibition system. However, even at the lowest stringency no hybridization was detected between diphtheria tox probe and P. aeruginosa DNA.
MATERIALS AND METHODS
Toxin A was purified as previously described (15) . Diphtheria toxin was obtained from Connaught Medical Research Laboratories, Toronto, Ontario, and further purified as previously described (22) . Diphtheria toxin was treated with trypsin and dithiothreitol (DTT) as described by Collier and Kandel (8) . Fragment A of diphtheria toxin was purified essentially as described by Collier and Kandel (8) . Fragment B of diphtheria toxin was purified by the method of Pappenheimer et al. (20) . Rabbits were hyperimmunized with toxin A (15), diphtheria toxoid, fragment A of diphtheria toxin, and partially purified fragment B of diphtheria toxin as previously described (17, 22) .
Phosphate-buffered saline for radioimmunoassay was Dulbecco phosphate-buffered saline (GIBCO Laboratories, Grand Island, N.Y.). The "filler" diluent contained 10% (vol/vol) fetal calf serum, 0.2% sodium azide, and 0.02% phenol red as described by Zollinger et al. (23) .
SPRIA inhibition. The SPRIA inhibition was performed essentially as described by Zollinger and Mandrell (24). Each rabbit serum was first tested for antibody levels by SPRIA against toxin A or diphtheria toxin in round-bottom microtiter plates (Cooke Laboratory Products, Inc., Alexandria, Va.) as described by Zollinger et al. (23) . Plates were sensitized with 25 p.l of a 50-p.g/ml solution of toxin. Goat antirabbit immunoglobulin, obtained from Antibodies Inc., Davis, Calif. and labeled by the lactoperoxidase method to a known specific activity (23) , was utilized as the secondary antibody. An estimate of the nanograms of antibody per milliliter in each serum specific for toxin A and diphtheria toxin was thereby obtained. The sera were diluted in filler diluent to approximately 100 ng of specific antibody per ml. This dilution of serum resulted in 20 to 30% of the maximum or plateau level of 125I bound. 100lo inhibition were found to be specific and reproducible in the toxin-antitoxin inhibition system. Zollinger and Mandrell found that background or nonspecific inhibition varied from 0 to 40% depending on the sera they used (24).
RPHA. Reversed passive hemagglutination assay (RPHA) was performed as described by Holmes et al. (10) , using immunoabsorbent-purified, sheep antitoxin A antibody-sensitized, formalized sheep erythrocytes (1). The RPHA endpoint represented the smallest quantity of the material tested that caused complete agglutination of sensitized SRBC. Controls as described by Holmes et al. (10) were included in all assays.
DNA/DNA hybridization. DNAs of tox+ corynebacteriophage 1-tsr-3, a heat-inducible mutant of 13-converting phage and of Corynebacterium diphtheriae strain C7(-), were isolated as recently described (2) ng of DNA per ml of hybridization fluid. Enzyme assay and neutralization by antibody. Enzyme neutralization assays were performed by incubating toxin A (100 ng; treated with urea and DTT) or fragment A of diphtheria toxin in 10 ,ul of 5% normal rabbit serum with an equal volume of immune serum for 10 min at 37°C as previously described (9, 13) . The ADP-ribose transferase activities of toxin A and fragment A of diphtheria toxin were then measured as described previously (13, 15) .
RESULTS AND DISCUSSION
The ability of toxin A, diphtheria toxin, diphtheria toxin treated with trypsin and DTT, and fragment A of diphtheria toxin to inhibit the reaction between rabbit antitoxin A (50 ng/ml, final concentration) and toxin A is shown in Fig.  1 . At final concentrations of 128 p.g/ml, trypsin-DTT-treated diphtheria toxin inhibited 90% of the toxin A-antitoxin A binding, fragment A of diphtheria toxin inhibited 84% of the reaction, and diphtheria toxin only inhibited between 20 and 30% of the binding. The inhibition seen with diphtheria toxin was probably nonspecific since inhibition did not increase with increasing concentrations of inhibitor. Trypsin alone as a control gave background levels of less than 20% inhibition (data not shown). In the range of inhibitor concentrations yielding 50 to 100% inhibition, trypsin-DTT-treated diphtheria toxin was as potent an inhibitor as toxin A itself (Fig.  1) . Toxin A was a more potent inhibitor than trypsin-DTT-treated diphtheria toxin or fragment A of diphtheria toxin at lower inhibitor concentrations. Concentrations of toxin A as low as 32 ng/ml produced 40%o inhibition, and concentrations in the range of 1 to 16 ng/ml produced 20 to 30% inhibition. In contrast, concentrations as high as 2,000 ng of trypsin-DTT-treated diphtheria toxin, or fragment A of diphtheria toxin, per ml produced only 20 to 30% inhibition.
Toxin A and diphtheria toxin therefore share an antigenic determinant which is highly accessible in toxin A but is readily accessible in diphtheria toxin only after the molecule is treated with trypsin and reducing agent. This determinant is probably located in the A portion of the diphtheria toxin molecule, as evidenced by the ability of purified fragment A of diphtheria toxin to inhibit the reaction to the same degree as trypsin-DTT-treated diphtheria toxin (Fig. 1) .
It would be tempting to assume that the crossreactive determinant was located in the enzyme- gions on fragment A of diphtheria toxin, only one being located in the enzyme-active site of the molecule. We are presently unable to distinguish between these two possibilities on the basis of our data.
The SPRIA inhibition technique primarily measures the ability of competing antigens to bind with the highest-titered antibody in the sera specific for those antigens. The antibody in highest titer against toxin A as measured in the solid-phase system was fully inhibited by the same concentrations of trypsin-DTT-treated diphtheria toxin and fragment A of diphtheria toxin as by toxin A itself (Fig. 1) . Therefore the immunodominant determinant of toxin A is very similar to the cross-reactive determinant on diphtheria toxin.
In contrast, antibodies against the cross-reactive determinant were not demonstrated when we examined reactions between diphtheria toxin and sera obtained from rabbits immunized with either diphtheria toxoid or fragment A or B of diphtheria toxin. The SPRIA reactions between these sera and diphtheria toxin were completely inhibited by diphtheria toxin and trypsin-DTTtreated diphtheria toxin, but were unaffected by toxin A (Table 1 ). The highest-titered antibodies in these sera were therefore directed against determinants other than those cross-reacting with toxin A. The cross-reactive determinant, when part of the diphtheria toxoid molecule or in the isolated fragment A of diphtheria toxin, is therefore not as good as immunogen as when found in toxin A. Our data are consistent with the proposal by Pappenheimer et al. (20) (12) .
The results (Fig. 2) showed that even at the 2 Fg of BamHl-digested whole-cell DNA from nonlysogenic C. diphtheriae strain C7(-). lowest stringency, no hybridization was detected between the diphtheria tox probe and strain PA103 DNA. In the positive control, only the fragment previously identified as the tox-bearing fragment of phage DNA hybridized to the probe. This result also demonstrated that the techniques employed could detect a sequence homologous to tox if it were present at an equivalent of one copy per bacterial genome copy. The negative control with C7(-) DNA in which no hybridization was seen showed that the probe contained only phage DNA. Similar results (data not shown) were obtained with DNA from P. aeruginosa PA01, a second toxin A-producing strain. From these data we conclude that there is no measurable homology between the tox gene of C. diphtheriae and the DNA of toxin Aproducing P. aeruginosa.
The results of the hybridization studies indicate that despite an identity in mode of action and evidence for cross-antigenic reactivity, the genes for diphtheria toxin and toxin A of P. aeruginosa are quite distinct in their nucleotide sequences. By way of comparison, DNA homology has recently been demonstrated between the LT-A and LT-B fragments of Escherichia coli LT toxin and the A and B fragments of cholera toxin (19) . Homology was detected under conditions in which a mismatch of base pairs of greater than 20%o was allowed for LT-A, and 36% was allowed for LT-B. Both A and B on October 27, 2017 by guest http://iai.asm.org/ Downloaded from fragments of E. coli LT toxin and cholera toxin show antigenic cross-reactivity (6), and both toxins share an affinity for similar cell receptors (11) .
Two interpretations can be given to our results. The first is that genes for diphtheria toxin and toxin A evolved independently, but that adaptation to a similar substrate resulted in enzymes which share a limited but antigenically active amino acid sequence. Alternatively, the genes for these toxins may have had a common ancestry, but over time lost significant homology. The former interpretation seems most likely, given the fact that homology would have been detected under conditions in which an average of one out of every three base pairs were mismatched. Amino acid sequencing of the toxins or nuceolotide sequencing of their genes will be required before a definitive interpretation of these results is possible.
